TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/27/25 17:12 | 6/25/25 | MXCT | Maxcyte, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Hemrajani Rekha | MD | D | S | -22 | 2.09 | 0 | -11 | -21 | 40 | D | |||||||||||||||
3/10/25 16:11 | 9/27/24 | BIOA | Bioage Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hemrajani Rekha | CA | D | P.a | 54 | 18.00 | 0 | 3 | New | 3 | D | |||||||||||||||
12/4/24 16:17 | 12/2/24 | ALXO | Alx Oncology Holdings Inc | DE | Health | Drug | Pharmaceutical Preparations | Hemrajani Rekha | CA | D | P | 46 | 1.55 | 0 | 30 | 999% | 33 | D | |||||||||||||||
7/21/20 20:03 | 7/21/20 | ALXO | Alx Oncology Holdings Inc | DE | Health | Drug | Pharmaceutical Preparations | Hemrajani Rekha | CA | D | P | 57 | 19.00 | 0 | 3 | New | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |